Drug Shortage Report for ABRAXANE FOR INJECTABLE SUSPENSION
| Report ID | 144114 |
| Drug Identification Number | 02281066 |
| Brand name | ABRAXANE FOR INJECTABLE SUSPENSION |
| Common or Proper name | paclitaxel |
| Company Name | CELGENE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PACLITAXEL |
| Strength(s) | 100MG |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | Vial |
| ATC code | L01CD |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-10-01 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2022-03-18 |
| Shortage status | Resolved |
| Updated date | 2022-03-28 |
| Company comments | Allocation will be based on historical demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2344 ALFRED-NOBEL BOULEVARD SAINT-LAURENT, QUEBEC CANADA H4S 0A4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v19 | 2022-03-28 | English | Compare |
| v18 | 2022-03-19 | English | Compare |
| v17 | 2022-03-18 | English | Compare |
| v16 | 2022-03-18 | French | Compare |
| v15 | 2022-03-18 | English | Compare |
| v14 | 2022-01-13 | French | Compare |
| v13 | 2021-10-02 | French | Compare |
| v12 | 2021-09-28 | French | Compare |
| v11 | 2021-09-28 | English | Compare |
| v10 | 2021-09-28 | French | Compare |
| v9 | 2021-09-28 | English | Compare |
| v8 | 2021-09-24 | French | Compare |
| v7 | 2021-09-24 | English | Compare |
| v6 | 2021-09-23 | French | Compare |
| v5 | 2021-09-23 | English | Compare |
| v4 | 2021-08-13 | French | Compare |
| v3 | 2021-08-13 | English | Compare |
| v2 | 2021-08-13 | French | Compare |
| v1 | 2021-08-13 | English | Compare |
Showing 1 to 19 of 19